Nima Shiva
Plus aucun poste en cours
Profil
Mr. Shiva has been in the life science industry since 1990 as a scientist, entrepreneur and investor.
As a Managing Director of Convergent Ventures, a life science venture investment and development group, he contributed to the formation of Neurion Pharmaceuticals and ORFID Corporation.
Mr. Shiva is also the Chairman, President and CEO of Encode Bio, a privately-held company which he spun out of Neurion in 2006.
Prior to joining Convergent Ventures, Mr. Shiva was an equity research associate in biotechnology and medical devices at Wedbush Morgan Securities.
From 1990 to 1998, Mr. Shiva held technical and research management positions at UC San Diego and Sequana Therapeutics.
Mr. Shiva holds an MBA from the University of Southern California and a BS in Physiology and Neurosciences from UC San Diego.
Anciens postes connus de Nima Shiva
| Sociétés | Poste | Fin |
|---|---|---|
Encode Bio, Inc.
 Encode Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Encode Bio, Inc. develops novel screening technologies to detect changes in protein conformations in response to pharmacological agents. The company was founded by Nima Shiva and is headquartered in Los Angeles, CA. | Directeur Général | 01/01/2015 |
Convergent Ventures LLC
 Convergent Ventures LLC Investment ManagersFinance Convergent Ventures LLC is a venture capital firm located in Los Angeles. The firm is headquartered in California. | Private Equity Investor | 01/01/2012 |
ORFID Corp.
 ORFID Corp. Electronic Production EquipmentElectronic Technology ORFID Corporation is an organic electronics company with a unique technology that will enable the manufacture of new products such as light-weight and flexible displays, smart labels and intelligent packaging. Electronic products made with organic components will be dramatically less costly to manufacture and more versatile than today's silicon-based products. ORFID is developing a new organic transistor, the Vertical Organic Field Effect Transistor (VOFET), to replace the conventional silicon semiconductor transistor technology currently used to manufacture products such as flat panel displays and radio frequency identification tags (RFIDs). The Company's initial focus is to enable the development of fully organic displays that are thin, flexible, and inexpensive to manufacture. Conventional organic transistor technologies are woefully inadequate for use in the manufacture of organic light-emitting diode (OLED) displays. Other organic transistors do not have the current-carrying capacity required to power OLEDs. With its unique device architecture, ORFID's VOFET is a potentially disruptive technology that can provide one thousand times the current of competing organic transistors at significantly lower operating voltages. In addition, the VOFET's unique architecture lends itself to simpler manufacture. The VOFET's superior current-carrying capacity and its novel architecture give ORFID a distinct technical advantage for exploiting organic transistors to manufacture OLED displays. ORFID will also leverage its core capabilities to develop and commercialize organic RFID technologies. Organic electronics are expected to enable low-cost, high volume RFID tagging of items, 10 trillion a year by some estimates. The inherent printability of organic electronics means that the production of organic devices may one day be combined with conventional printing and packaging processes, allowing the fabrication of products such as smart packages, papers and textiles in the same pass. ORFID's organic electronic technologies and patent portfolio allow it to decisively enter this market place in the area of low cost printable electronics for the manufacture of RFID tags. | Corporate Officer/Principal | 30/11/2010 |
Neurion Pharmaceuticals, Inc.
 Neurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurion Pharmaceuticals, Inc. provides pharmaceutical products. It develops novel molecule drugs for the treatment of central nervous system disorders such as schizophrenia, chronic pain, and Alzheimer's disease. The company was co-founded by Dr. Henry A. Lester, William L. Robbins, and Dr. Dennis A. Dougherty in January, 2002 and is headquartered in Pasadena, CA. | Directeur/Membre du Conseil | 01/01/2009 |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01/01/2000 |
Formation de Nima Shiva
| University of Southern California | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
ORFID Corp.
ORFID Corp. Electronic Production EquipmentElectronic Technology ORFID Corporation is an organic electronics company with a unique technology that will enable the manufacture of new products such as light-weight and flexible displays, smart labels and intelligent packaging. Electronic products made with organic components will be dramatically less costly to manufacture and more versatile than today's silicon-based products. ORFID is developing a new organic transistor, the Vertical Organic Field Effect Transistor (VOFET), to replace the conventional silicon semiconductor transistor technology currently used to manufacture products such as flat panel displays and radio frequency identification tags (RFIDs). The Company's initial focus is to enable the development of fully organic displays that are thin, flexible, and inexpensive to manufacture. Conventional organic transistor technologies are woefully inadequate for use in the manufacture of organic light-emitting diode (OLED) displays. Other organic transistors do not have the current-carrying capacity required to power OLEDs. With its unique device architecture, ORFID's VOFET is a potentially disruptive technology that can provide one thousand times the current of competing organic transistors at significantly lower operating voltages. In addition, the VOFET's unique architecture lends itself to simpler manufacture. The VOFET's superior current-carrying capacity and its novel architecture give ORFID a distinct technical advantage for exploiting organic transistors to manufacture OLED displays. ORFID will also leverage its core capabilities to develop and commercialize organic RFID technologies. Organic electronics are expected to enable low-cost, high volume RFID tagging of items, 10 trillion a year by some estimates. The inherent printability of organic electronics means that the production of organic devices may one day be combined with conventional printing and packaging processes, allowing the fabrication of products such as smart packages, papers and textiles in the same pass. ORFID's organic electronic technologies and patent portfolio allow it to decisively enter this market place in the area of low cost printable electronics for the manufacture of RFID tags. | Electronic Technology |
Neurion Pharmaceuticals, Inc.
Neurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurion Pharmaceuticals, Inc. provides pharmaceutical products. It develops novel molecule drugs for the treatment of central nervous system disorders such as schizophrenia, chronic pain, and Alzheimer's disease. The company was co-founded by Dr. Henry A. Lester, William L. Robbins, and Dr. Dennis A. Dougherty in January, 2002 and is headquartered in Pasadena, CA. | Health Technology |
Convergent Ventures LLC
Convergent Ventures LLC Investment ManagersFinance Convergent Ventures LLC is a venture capital firm located in Los Angeles. The firm is headquartered in California. | Finance |
Encode Bio, Inc.
Encode Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Encode Bio, Inc. develops novel screening technologies to detect changes in protein conformations in response to pharmacological agents. The company was founded by Nima Shiva and is headquartered in Los Angeles, CA. | Commercial Services |
